Literature DB >> 14725869

Internal cue exposure and the treatment of substance use disorders: lessons from the treatment of panic disorder.

Michael W Otto1, Steven A Safren, Mark H Pollack.   

Abstract

Despite early recognition of the importance of internal cues (craving sensations and emotional states) for relapse in substance use disorders, relatively little attention has been devoted to exposure-based treatments targeting these cues. Drawing upon research on the conceptualization and treatment of panic disorder, we discuss the application of internal (largely emotional) cue exposure for substance use disorders. Our model for this discussion was based on the role of exposure to feared sensations of anxiety in the treatment of panic disorder and benzodiazepine (BZ) discontinuation. Shared research strategies between panic disorder and substance use--studies of biological provocation and anxiety sensitivity--were discussed, as were gender differences in drug-use motives. In accordance with research on anxiety sensitivity, provocation effects, and the treatment of benzodiazepine withdrawal, we discussed the potential value of internal cue-exposure strategies for individuals who use substances as a way to cope with negative affect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14725869     DOI: 10.1016/j.janxdis.2003.07.007

Source DB:  PubMed          Journal:  J Anxiety Disord        ISSN: 0887-6185


  15 in total

1.  Deepened extinction following compound stimulus presentation: noradrenergic modulation.

Authors:  Patricia H Janak; Laura H Corbit
Journal:  Learn Mem       Date:  2010-12-14       Impact factor: 2.460

2.  Chronic modafinil effects on drug-seeking following methamphetamine self-administration in rats.

Authors:  Carmela M Reichel; Ronald E See
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

3.  Initial RCT of a distress tolerance treatment for individuals with substance use disorders.

Authors:  Marina A Bornovalova; Kim L Gratz; Stacey B Daughters; Elizabeth D Hunt; C W Lejuez
Journal:  Drug Alcohol Depend       Date:  2011-10-07       Impact factor: 4.492

Review 4.  Cognitive behavioral therapy for substance use disorders.

Authors:  R Kathryn McHugh; Bridget A Hearon; Michael W Otto
Journal:  Psychiatr Clin North Am       Date:  2010-09

5.  Efficacy of CBT for benzodiazepine discontinuation in patients with panic disorder: Further evaluation.

Authors:  Michael W Otto; R Kathryn McHugh; Naomi M Simon; Frank J Farach; John J Worthington; Mark H Pollack
Journal:  Behav Res Ther       Date:  2010-04-28

6.  Benzodiazepines: Revisiting Clinical Issues in Treating Anxiety Disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

7.  Modifying Exposure-Based CBT for Cambodian Refugees with Posttraumatic Stress Disorder.

Authors:  Michael W Otto; Devon E Hinton
Journal:  Cogn Behav Pract       Date:  2006-11-01

8.  Rates of mood and anxiety disorders and contributors to continued heroin use in methadone maintenance patients: A comparison by HIV status.

Authors:  Allison J Applebaum; Jacqueline R Bullis; Lara N Traeger; Conall O'cleirigh; Michael W Otto; Mark H Pollack; Steven A Safren
Journal:  Neurobehav HIV Med       Date:  2010-08-10

9.  Anxiety sensitivity: a unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment.

Authors:  C W Lejuez; Michael J Zvolensky; Stacey B Daughters; Marina A Bornovalova; Autumn Paulson; Matthew T Tull; Kenneth Ettinger; Michael W Otto
Journal:  Behav Res Ther       Date:  2008-03-28

10.  Attending to emotional cues for drug abuse: bridging the gap between clinic and home behaviors.

Authors:  Michael W Otto; Conall M O' Cleirigh; Mark H Pollack
Journal:  Sci Pract Perspect       Date:  2007-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.